SCHEMBL4301624

SCHEMBL4301624

COCCCOc1cc(C[C@@H](CC2CN(C(=O)OC(C)(C)C)CC2CO)C(C)C)ccc1OC

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.46
REN P00797 18/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4301751 1.00 PDE4B (0.46) PDE4BREN
SCHEMBL4112225 1.00 PDE4B (0.46) PDE4BREN
SCHEMBL4300435 1.00 PDE4B (0.46) PDE4BREN
SCHEMBL4301627 1.00 PDE4B (0.46) PDE4BREN
SCHEMBL4351288 0.91 REN (0.46) PDE4BREN
SCHEMBL4351285 0.91 REN (0.46) PDE4BREN
SCHEMBL4351292 0.91 REN (0.46) PDE4BREN
SCHEMBL3977593 0.90 PDE4B (0.49) PDE4BREN
SCHEMBL3977592 0.90 PDE4B (0.49) PDE4BREN
SCHEMBL4300655 0.90 REN (0.44) PDE4BREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270417-A1 Organic Compounds NOVARTIS AG (CH) 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270417-A1 Organic Compounds REN, ACE, OTC PDE4B 619/4885REN 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.